PD-0325901
To Order Contact us: lieven@wlsolutions.be
PD-1/PD-L1 inhibitor 2 |
||
| B6023-25 | 25 mg | EUR 438 |
|
Description: PD-1/PD-L1 inhibitor 2 is a PD-1/PD-L1 interaction inhibitor. |
||
PD-1/PD-L1 inhibitor 2 |
||
| B6023-5 | 5 mg | EUR 171 |
|
Description: PD-1/PD-L1 inhibitor 2 is a PD-1/PD-L1 interaction inhibitor. |
||
PD-1/PD-L1 inhibitor 1 |
||
| B6172-25 | 25 mg | EUR 453 |
|
Description: IC50: 0.006-0.10 ?MPD-1/PD-L1 inhibitor 1 is a PD-1/PD-L1 interaction inhibitor.Plenty of studies show that blocking the PD-1/PD-Ll interactions can lead to the restorage and augment of T cell activation in many systems. |
||
PD-1/PD-L1 inhibitor 1 |
||
| B6172-5 | 5 mg | EUR 168 |
|
Description: IC50: 0.006-0.10 ?MPD-1/PD-L1 inhibitor 1 is a PD-1/PD-L1 interaction inhibitor.Plenty of studies show that blocking the PD-1/PD-Ll interactions can lead to the restorage and augment of T cell activation in many systems. |
||
PD-1/PD-L1 Inhibitor 2 |
||
| B1050-25 | EUR 566 | |
PD-1/PD-L1 Inhibitor 2 |
||
| B1050-5 | EUR 202 | |
PD-1/PD-L1 Inhibitor 1 |
||
| B1213-25 | EUR 566 | |
PD-1/PD-L1 Inhibitor 1 |
||
| B1213-5 | EUR 185 | |
PD 117519 |
||
| HY-100032 | 5mg | EUR 119 |
PD-166866 |
||
| HY-101296 | 10mM/1mL | EUR 138 |
PD-159020 |
||
| HY-101598 | 1mg | EUR 1125 |
PD 123319 |
||
| HY-10259 | 5mg | EUR 182 |
PD 169316 |
||
| HY-10578 | 10mM/1mL | EUR 255 |
PD 90780 |
||
| HY-110166 | 5mg | EUR 326 |
PD 407824 |
||
| HY-18961 | 100mg | EUR 1542 |
PD 151746 |
||
| HY-19749 | 50mg | EUR 491 |
PD 0332991 |
||
| E1KS1116 | 5mg | EUR 677 |
PD 150,606 |
||
| GL2543-25MG | 25 mg | EUR 413 |
PD 150,606 |
||
| GL2543-5MG | 5 mg | EUR 154 |
PD 98,059 |
||
| GK2140-10MG | 10 mg | EUR 172 |
PD 98,059 |
||
| GK2140-1MG | 1 mg | EUR 91 |
PD 98,059 |
||
| GK2140-50MG | 50 mg | EUR 378 |
PD 98,059 |
||
| GK2140-5MG | 5 mg | EUR 137 |
PD 151746 |
||
| B4791-100 | 100 mg | EUR 595 |
|
Description: PD 151746 is a potent and selective inhibitor of calpain with Ki value of 0.26 ?M for ?-Calpain. Calpain is a calcium-dependent, non-lysosomal cysteine protease that expressed in mammals and many other organisms. |
||
PD 151746 |
||
| B4791-25 | 25 mg | EUR 282 |
|
Description: PD 151746 is a potent and selective inhibitor of calpain with Ki value of 0.26 ?M for ?-Calpain. Calpain is a calcium-dependent, non-lysosomal cysteine protease that expressed in mammals and many other organisms. |
||
PD 151746 |
||
| B4791-5 | 5 mg | EUR 119 |
|
Description: PD 151746 is a potent and selective inhibitor of calpain with Ki value of 0.26 ?M for ?-Calpain. Calpain is a calcium-dependent, non-lysosomal cysteine protease that expressed in mammals and many other organisms. |
||
PD 151746 |
||
| B4791-5.1 | 10 mM (in 1mL DMSO) | EUR 126 |
|
Description: PD 151746 is a potent and selective inhibitor of calpain with Ki value of 0.26 ?M for ?-Calpain. Calpain is a calcium-dependent, non-lysosomal cysteine protease that expressed in mammals and many other organisms. |
||
PD 334581 |
||
| B5727-10 | 10 mg | EUR 486 |
PD 334581 |
||
| B5727-50 | 50 mg | EUR 1850 |
PD 150606 |
||
| A4413-25 | 25 mg | EUR 428 |
|
Description: PD 150606 is a specific inhibitor of calpain with Ki value of 0.21 ?M and 0.37 ?M for mu- and m- calpains, respectively [1]. |
||
PD 150606 |
||
| A4413-5 | 5 mg | EUR 144 |
|
Description: PD 150606 is a specific inhibitor of calpain with Ki value of 0.21 ?M and 0.37 ?M for mu- and m- calpains, respectively [1]. |
||
PD 166793 |
||
| A4438-10 | 10 mg | EUR 242 |
|
Description: Broad spectrum MMP inhibitor. Displays high affinity for MMP-2, -3 and -13 (IC50 values are 4, 7 and 8 nM respectively) and exhibits > 750-fold selectivity over MMP-1, -7 and -9. Attenuates left ventricular remodelling and dysfunction in rat model of heart failure. |
||
PD 166793 |
||
| A4438-25 | 25 mg | EUR 498 |
|
Description: Broad spectrum MMP inhibitor. Displays high affinity for MMP-2, -3 and -13 (IC50 values are 4, 7 and 8 nM respectively) and exhibits > 750-fold selectivity over MMP-1, -7 and -9. Attenuates left ventricular remodelling and dysfunction in rat model of heart failure. |
||
PD 166793 |
||
| A4438-5 | 5 mg | EUR 187 |
|
Description: Broad spectrum MMP inhibitor. Displays high affinity for MMP-2, -3 and -13 (IC50 values are 4, 7 and 8 nM respectively) and exhibits > 750-fold selectivity over MMP-1, -7 and -9. Attenuates left ventricular remodelling and dysfunction in rat model of heart failure. |
||
PD 158780 |
||
| B7130-10 | 10 mg | EUR 232 |
PD 158780 |
||
| B7130-25 | 25 mg | EUR 453 |
PD 158780 |
||
| B7130-5 | 5 mg | EUR 151 |
PD 118057 |
||
| B7203-10 | 10 mg | EUR 334 |
PD 118057 |
||
| B7203-50 | 50 mg | EUR 1243 |
PD 146176 |
||
| B7208-10 | 10 mg | EUR 150 |
PD 146176 |
||
| B7208-25 | 25 mg | EUR 287 |
PD 146176 |
||
| B7208-50 | 50 mg | EUR 473 |
PD 173212 |
||
| B7424-10 | 10 mg | EUR 529 |
PD 173212 |
||
| B7424-5 | 5 mg | EUR 376 |
PD 173212 |
||
| B7424-5.1 | 10 mM (in 1mL DMSO) | EUR 479 |
PD 161570 |
||
| B7486-10 | 10 mg | EUR 454 |
PD 161570 |
||
| B7486-50 | 50 mg | EUR 1714 |
PD 145305 |
||
| C5830-10 | 10 mg | EUR 428 |
|
Description: PD 145305 is an inactive analog of PD 150606, a potent and selective calpains inhibitor [1]. Calpain is a class of cytosolic cysteine protease that is activated by elevated intracellular calcium. |
||
PD 145305 |
||
| C5830-5 | 5 mg | EUR 263 |
|
Description: PD 145305 is an inactive analog of PD 150606, a potent and selective calpains inhibitor [1]. Calpain is a class of cytosolic cysteine protease that is activated by elevated intracellular calcium. |
||
PD-ECGF |
||
| PR15044 | 10 ug | EUR 487 |
PD-ECGF |
||
| GT15181 | 100 ug | EUR 526 |
PD 166326 |
||
| C3677-1 | 1 mg | EUR 161 |
|
Description: IC50: 8 nM for c-abl PD 166326 is a receptor tyrosine kinase inhibitor.Receptor tyrosine kinases are the high-affinity cell surface receptors for many growth factors, cytokines, as well as hormones. |
||
PD 166326 |
||
| C3677-10 | 10 mg | EUR 940 |
|
Description: IC50: 8 nM for c-abl PD 166326 is a receptor tyrosine kinase inhibitor.Receptor tyrosine kinases are the high-affinity cell surface receptors for many growth factors, cytokines, as well as hormones. |
||
PD 166326 |
||
| C3677-5 | 5 mg | EUR 551 |
|
Description: IC50: 8 nM for c-abl PD 166326 is a receptor tyrosine kinase inhibitor.Receptor tyrosine kinases are the high-affinity cell surface receptors for many growth factors, cytokines, as well as hormones. |
||
PD 173074 |
||
| A8253-10 | 10 mg | EUR 108 |
|
Description: PD173074 is a poten and selective fibroblast growth factor receptor (FGFR) inhibitor. Fibroblast growth factor-2 is reported to be able to induce proliferation and chemoresistance in Small cell lung cancer (SCLC) cells. |
||
PD 173074 |
||
| A8253-5.1 | 10 mM (in 1mL DMSO) | EUR 119 |
|
Description: PD173074 is a poten and selective fibroblast growth factor receptor (FGFR) inhibitor. Fibroblast growth factor-2 is reported to be able to induce proliferation and chemoresistance in Small cell lung cancer (SCLC) cells. |
||
PD 173074 |
||
| A8253-50 | 50 mg | EUR 212 |
|
Description: PD173074 is a poten and selective fibroblast growth factor receptor (FGFR) inhibitor. Fibroblast growth factor-2 is reported to be able to induce proliferation and chemoresistance in Small cell lung cancer (SCLC) cells. |
||
PD 173074 |
||
| A8253-S | Evaluation Sample | EUR 81 |
|
Description: PD173074 is a poten and selective fibroblast growth factor receptor (FGFR) inhibitor. Fibroblast growth factor-2 is reported to be able to induce proliferation and chemoresistance in Small cell lung cancer (SCLC) cells. |
||
PD 180970 |
||
| A8606-10 | 10 mg | EUR 431 |
|
Description: ATP-competitive inhibitor of p210bcr/abl tyrosine kinase; selectively induces apoptosis in chronic myeloid leukemia (CML) K562 cells. Inhibits in vivo tyrosine phosphorylation of Gab2, CrkL and p210bcr/abl (IC50 values are 80, 80 and 170 nM respectively). |
||
PD 169316 |
||
| A8689-10 | 10 mg | EUR 163 |
|
Description: IC50: A potent, selective and cell-permeable suppressor of p38 MAP kinase, with the IC50 value of 89 nM.PD169316, a specific p38 MAPK inhibitor, blocks signal transduction mediated by both TGF-? and Activin A, but not bone morphogenetic protein (BMP) 4. |
||
PD 169316 |
||
| A8689-5.1 | 10 mM (in 1mL DMSO) | EUR 224 |
|
Description: IC50: A potent, selective and cell-permeable suppressor of p38 MAP kinase, with the IC50 value of 89 nM.PD169316, a specific p38 MAPK inhibitor, blocks signal transduction mediated by both TGF-? and Activin A, but not bone morphogenetic protein (BMP) 4. |
||
PD 169316 |
||
| A8689-50 | 50 mg | EUR 496 |
|
Description: IC50: A potent, selective and cell-permeable suppressor of p38 MAP kinase, with the IC50 value of 89 nM.PD169316, a specific p38 MAPK inhibitor, blocks signal transduction mediated by both TGF-? and Activin A, but not bone morphogenetic protein (BMP) 4. |
||
PD 184161 |
||
| C4361-10 | 10 mg | EUR 283 |
|
Description: IC50: 10-100 nMPD 184161 is a MEK1/2 inhibitor. The intracellular signaling pathway of mitogen-activated protein kinases is involved in the regulation of various cellular functions. |
||
PD 184161 |
||
| C4361-25 | 25 mg | EUR 561 |
|
Description: IC50: 10-100 nMPD 184161 is a MEK1/2 inhibitor. The intracellular signaling pathway of mitogen-activated protein kinases is involved in the regulation of various cellular functions. |
||
PD 184161 |
||
| C4361-5 | 5 mg | EUR 181 |
|
Description: IC50: 10-100 nMPD 184161 is a MEK1/2 inhibitor. The intracellular signaling pathway of mitogen-activated protein kinases is involved in the regulation of various cellular functions. |
||
PD 81723 |
||
| B6705-10 | 10 mg | EUR 284 |
PD 81723 |
||
| B6705-50 | 50 mg | EUR 1038 |
PD 102807 |
||
| B6821-10 | 10 mg | EUR 389 |
PD 102807 |
||
| B6821-50 | 50 mg | EUR 1476 |
PD 160170 |
||
| B6972-10 | 10 mg | EUR 340 |
PD 176252 |
||
| B7122-10 | 10 mg | EUR 512 |
PD 198306 |
||
| B7124-1 | 1 mg | EUR 126 |
|
Description: IC50: 8 nM for MEK [1]PD 198306 is a potent, selective and non-ATP competitive MAPK/ERK-kinase (MEK) inhibitor. MEK is a kinase enzyme which phosphorylates mitogen-activated protein kinase (MAPK). |
||
PD 198306 |
||
| B7124-10 | 10 mg | EUR 529 |
|
Description: IC50: 8 nM for MEK [1]PD 198306 is a potent, selective and non-ATP competitive MAPK/ERK-kinase (MEK) inhibitor. MEK is a kinase enzyme which phosphorylates mitogen-activated protein kinase (MAPK). |
||
PD 198306 |
||
| B7124-5 | 5 mg | EUR 318 |
|
Description: IC50: 8 nM for MEK [1]PD 198306 is a potent, selective and non-ATP competitive MAPK/ERK-kinase (MEK) inhibitor. MEK is a kinase enzyme which phosphorylates mitogen-activated protein kinase (MAPK). |
||
PD 135158 |
||
| B7127-10 | 10 mg | EUR 486 |
PD 135158 |
||
| B7127-50 | 50 mg | EUR 1850 |
PD 169316 |
||
| B1703-25 | EUR 544 | |
PD 169316 |
||
| B1703-5 | EUR 175 | |
PD-166866 |
||
| B2223-25 | EUR 675 | |
PD-166866 |
||
| B2223-5 | EUR 207 | |
PD-146176 |
||
| B2313-25 | EUR 675 | |
PD-146176 |
||
| B2313-5 | EUR 207 | |
PD-168393 |
||
| B2352-25 | EUR 414 | |
PD-168393 |
||
| B2352-5 | EUR 142 | |
PD 98059 |
||
| 1666-5 | EUR 158 | |
PD 173074 |
||
| 1675-1 | EUR 137 | |
PD 173074 |
||
| 1675-100 | Ask for price | |
PD 150,606 |
||
| 1906-25 | EUR 370 | |
PD 150,606 |
||
| 1906-5 | EUR 137 | |
Ribosome-inactivating protein PD-L1 / PD-L2 Antibody |
||
| 20-abx319445 |
|
|
Ribosome-inactivating protein PD-L1/PD-L2 Antibody |
||
| 1-CSB-PA306294LA01PJJ |
|
|
|
Description: A polyclonal antibody against Ribosome-inactivating protein PD-L1/PD-L2. Recognizes Ribosome-inactivating protein PD-L1/PD-L2 from Phytolacca dioica. This antibody is Unconjugated. Tested in the following application: ELISA |
||
PD 123319 (ditrifluoroacetate) |
||
| HY-10259A | 10mg | EUR 215 |
(+)-PD 128907 hydrochloride |
||
| HY-110000 | 50mg | EUR 751 |
PD-168077 maleate |
||
| HY-21098A | 10mM/1mL | EUR 176 |
PD-1,CD279 |
||
| E6TA00107 | 0.1mg | EUR 343 |
PD-L1, CD274 |
||
| E6TA00108 | 0.1mg | EUR 343 |